Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities

Ontogenetic abnormalities in the regulation of the cortical cholinergic input system are hypothesized to mediate early-life cognitive limitations (ECL) that later escalate, based on reciprocal interactions between a dysregulated cholinergic system and age-related neuronal and vascular processes, to mild cognitive impairment (MCI) and, subsequently, for a majority of subjects, senile dementia. This process is speculated to begin with the disruption of trophic factor support of the basal forebrain ascending cholinergic system early in life, leading to dysregulation of cortical cholinergic transmission during the initial decades of life and associated limitations in cognitive capacities. Results from neurochemical and behavioral experiments support the possibility that aging reveals the vulnerability of an abnormally regulated cortical cholinergic input system. The decline of the cholinergic system is further accelerated as a result of interactions with amyloid precursor protein metabolism and processing, and with cerebral microvascular abnormalities. The determination of the developmental variables that render the cortical cholinergic input system vulnerable to age-related processes represents an important step toward the understanding of the role of this neuronal system in the age-related decline in cognitive functions.

[1]  J. Schneider,et al.  Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease , 2002, Annals of neurology.

[2]  T. Robbins,et al.  Central cholinergic systems and cognition. , 1997, Annual review of psychology.

[3]  A. Cuello,et al.  Age-related variations in plasticity of rat basal forebrain cholinergic neurons after cortical lesions , 1988, Brain Research.

[4]  E. Masliah,et al.  E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer’s disease , 2000, Neurology.

[5]  L. Thal,et al.  Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients , 2000, Neurobiology of Aging.

[6]  Matcheri S. Keshavan,et al.  Toward a Neurodevelopmental Model of Obsessive–Compulsive Disorder , 1998, Biological Psychiatry.

[7]  M. Sarter,et al.  Sustained Visual Attention Performance-Associated Prefrontal Neuronal Activity: Evidence for Cholinergic Modulation , 2000, The Journal of Neuroscience.

[8]  E. Tani,et al.  Cytotoxic Fragment of Amyloid Precursor Protein Accumulates in Hippocampus after Global Forebrain Ischemia , 1996, Journal of Cerebral Blood Flow and Metabolism.

[9]  J. Blusztajn,et al.  Choline, a Vital Amine , 1998, Science.

[10]  J. Buccafusco,et al.  The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development , 2003, Journal of Pharmacology and Experimental Therapeutics.

[11]  C. Geula,et al.  Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. , 1996, Cerebral cortex.

[12]  Steffen Roßner,et al.  The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling , 1998, Progress in Neurobiology.

[13]  M. Crossley,et al.  Age-related differences in concurrent-task performance of normal adults: evidence for a decline in processing resources. , 1992, Psychology and aging.

[14]  J. Turchi,et al.  Age- and Dementia-Associated Impairments in Divided Attention: Psychological Constructs, Animal Models, and Underlying Neuronal Mechanisms , 2001, Dementia and Geriatric Cognitive Disorders.

[15]  T. Hortobágyi,et al.  Functional Recovery of Cholinergic Basal Forebrain Neurons under Disease Conditions: Old Problems, New Solutions? , 2002, Reviews in the neurosciences.

[16]  T. Crook,et al.  Diagnosis, assessment and treatment of age-associated memory impairment. , 1991, Journal of neural transmission. Supplementum.

[17]  J. Hodges,et al.  Attention and executive deficits in Alzheimer's disease. A critical review. , 1999, Brain : a journal of neurology.

[18]  P. Luiten,et al.  Cerebral microvascular pathology in aging and Alzheimer's disease , 2001, Progress in Neurobiology.

[19]  T. Deacon,et al.  Chronic cognitive deficits and amyloid precursor protein elevation after selective immunotoxin lesions of the basal forebrain cholinergic system , 1998, Neuroreport.

[20]  F. Kagitani,et al.  Effects of age on cholinergic vasodilation of cortical cerebral blood vessels in rats , 2000, Neuroscience Letters.

[21]  Raja Parasuraman,et al.  Alzheimer disease constricts the dynamic range of spatial attention in visual search , 2000, Neuropsychologia.

[22]  R. Cowburn,et al.  Receptor‐Effector Coupling Dysfunctions in Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.

[23]  N. Lavine,et al.  Reduction in p140-TrkA Receptor Protein within the Nucleus Basalis and Cortex in Alzheimer's Disease , 1997, Experimental Neurology.

[24]  L S Honig,et al.  Aging and Alzheimer's disease: lessons from the Nun Study. , 1998, The Gerontologist.

[25]  D. Selkoe Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[26]  E. Hamel,et al.  Cholinergic basal forebrain neurons project to cortical microvessels in the rat: electron microscopic study with anterogradely transported Phaseolus vulgaris leucoagglutinin and choline acetyltransferase immunocytochemistry , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  Roberta F. White,et al.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. , 2000, Archives of neurology.

[28]  M. Sofroniew,et al.  Nerve growth factor signaling, neuroprotection, and neural repair. , 2001, Annual review of neuroscience.

[29]  R. Kalaria Small Vessel Disease and Alzheimer’s Dementia: Pathological Considerations , 2002, Cerebrovascular Diseases.

[30]  C. Iadecola,et al.  Increased Susceptibility to Ischemic Brain Damage in Transgenic Mice Overexpressing the Amyloid Precursor Protein , 1997, The Journal of Neuroscience.

[31]  A. Björklund,et al.  Experimental studies on the induction and prevention of retrograde degeneration of basal forebrain cholinergic neurons. , 1986, Progress in brain research.

[32]  L. Descarries,et al.  Ultrastructural features of the acetylcholine innervation in the developing parietal cortex of rat , 2002, The Journal of comparative neurology.

[33]  H. Phillips,et al.  Disruption of a Single Allele of the Nerve Growth Factor Gene Results in Atrophy of Basal Forebrain Cholinergic Neurons and Memory Deficits , 1997 .

[34]  Edward J. Golob,et al.  Sensory cortical interactions in aging, mild cognitive impairment, and Alzheimer’s disease , 2001, Neurobiology of Aging.

[35]  J. Haxby,et al.  Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  L. Butcher,et al.  Postnatal development of cholinergic neurons in the rat: I. Forebrain , 1991, Brain Research Bulletin.

[37]  G. Sedvall,et al.  SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP , 2001, European Journal of Nuclear Medicine.

[38]  R. Quirion,et al.  β-Amyloid peptides as direct cholinergic neuromodulators: a missing link? , 1998, Trends in Neurosciences.

[39]  E. Cochran,et al.  Down‐regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease , 2001, The Journal of comparative neurology.

[40]  S. Leurgans,et al.  Loss of basal forebrain P75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease , 2002, The Journal of comparative neurology.

[41]  Arthur D. Fisk,et al.  Aging and Skilled Performance : Advances in Theory and Applications , 1996 .

[42]  A. D. Smith,et al.  Effects of age and a divided attention task presented during encoding and retrieval on memory. , 1989, Journal of experimental psychology. Learning, memory, and cognition.

[43]  T. Harkany,et al.  Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca2+ antagonist nimodipine , 2000, Neuroscience.

[44]  D. Butterfield,et al.  Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death , 2002, Neurobiology of Aging.

[45]  F. Craik,et al.  Effects of aging and task difficulty on divided attention performance. , 1988, Journal of experimental psychology. Human perception and performance.

[46]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[47]  T. Nabeshima,et al.  Amyloid β-peptide induces cholinergic dysfunction and cognitive deficits: a minireview , 2002, Peptides.

[48]  L. Descarries,et al.  The cholinergic innervation develops early and rapidly in the rat cerebral cortex: a quantitative immunocytochemical study , 2001, Neuroscience.

[49]  R. Quirion,et al.  Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. , 2002, Progress in neurobiology.

[50]  A. Granholm,et al.  Loss of Cholinergic Phenotype in Basal Forebrain Coincides with Cognitive Decline in a Mouse Model of Down's Syndrome , 2000, Experimental Neurology.

[51]  S. Wisniewski,et al.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment , 2002, Annals of neurology.

[52]  D. Surmon,et al.  Longitudinal diagnosis of memory disorders. , 1992, Age and ageing.

[53]  Laura Fratiglioni,et al.  What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment , 2003, Acta neurologica Scandinavica. Supplementum.

[54]  T. Slotkin,et al.  Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood. , 2002, Environmental health perspectives.

[55]  A. Nuñez,et al.  Electrophysiological evidence for the existence of a posterior cortical–prefrontal–basal forebrain circuitry in modulating sensory responses in visual and somatosensory rat cortical areas , 2003, Neuroscience.

[56]  D. Hogan,et al.  Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. , 1995, Archives of neurology.

[57]  P. S. St George-Hyslop,et al.  Prediction of probable Alzheimer's disease in memory-impaired patients , 1996, Neurology.

[58]  E. Tangalos,et al.  Mild cognitive impairment in the oldest old , 2003, Neurology.

[59]  M. Hayashi,et al.  Changes in BDNF-immunoreactive structures in the hippocampal formation of the aged macaque monkey , 2001, Brain Research.

[60]  M. Frotscher,et al.  Complete Deletion of the Neurotrophin Receptor p75NTRLeads to Long-Lasting Increases in the Number of Basal Forebrain Cholinergic Neurons , 2002, The Journal of Neuroscience.

[61]  D. Bredesen,et al.  p75NTR and apoptosis: Trk-dependent and Trk-independent effects , 1997, Trends in Neurosciences.

[62]  L. Nyberg,et al.  Effects of division of attention during encoding and retrieval on age differences in episodic memory. , 1997, Experimental aging research.

[63]  J. Hodges,et al.  Relationship between functional and neuropsychological performance in early Alzheimer disease. , 2000, Alzheimer disease and associated disorders.

[64]  C. Lyketsos,et al.  Cognitive decline in adulthood: an 11.5-year follow-up of the Baltimore Epidemiologic Catchment Area study. , 1999, The American journal of psychiatry.

[65]  J. Growdon,et al.  Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. , 1992, Science.

[66]  C. Masters,et al.  Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease , 1999, Annals of neurology.

[67]  A. Baddeley,et al.  Autobiographical memory and executive function in early dementia of Alzheimer type , 1995, Neuropsychologia.

[68]  W. Mcentee,et al.  Age-associated memory impairment , 1995, Neurology.

[69]  L. Giambra,et al.  Sustained attention and aging: overcoming the decrement? , 1997, Experimental aging research.

[70]  M. Sarter,et al.  Increases in cortical acetylcholine release during sustained attention performance in rats. , 2000, Brain research. Cognitive brain research.

[71]  P. Holland,et al.  Basal forebrain cholinergic lesions disrupt increments but not decrements in conditioned stimulus processing , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[72]  M. Nissen,et al.  Attentional requirements of learning: Evidence from performance measures , 1987, Cognitive Psychology.

[73]  S. Ferris,et al.  Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work group , 1986 .

[74]  C. Hohmann A morphogenetic role for acetylcholine in mouse cerebral neocortex , 2003, Neuroscience & Biobehavioral Reviews.

[75]  L. Thal,et al.  Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. , 1995, Archives of neurology.

[76]  S. Gauthier,et al.  Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[77]  J. Wess,et al.  Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[78]  M. Stryker,et al.  Infusion of nerve growth factor (NGF) into kitten visual cortex increases immunoreactivity for NGF, NGF receptors, and choline acetyltransferase in basal forebrain without affecting ocular dominance plasticity or column development , 2001, Neuroscience.

[79]  J. Yakel,et al.  β-Amyloid1–42 Peptide Directly Modulates Nicotinic Receptors in the Rat Hippocampal Slice , 2001, The Journal of Neuroscience.

[80]  R. Quirion,et al.  Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. , 1998, Journal of neurochemistry.

[81]  J. Haxby,et al.  Attentional costs of mental operations in young and old adults , 1989 .

[82]  J. Morris Challenging assumptions about Alzheimer's disease: Mild cognitive impairment and the cholinergic hypothesis , 2002, Annals of neurology.

[83]  D A Bennett,et al.  Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease , 1999, The Journal of comparative neurology.

[84]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[85]  M. Sarter,et al.  Cortical cholinergic inputs mediate processing capacity: effects of 192 IgG‐saporin‐induced lesions on olfactory span performance , 2000, The European journal of neuroscience.

[86]  R. Hellweg,et al.  Insights Into the Role of the Cholinergic Component of the Septohippocampal Pathway: What Have We Learned from Experimental Lesion Studies? , 1997, Brain Research Bulletin.

[87]  L. Ricceri,et al.  Early neonatal 192 IgG saporin induces learning impairments and disrupts cortical morphogenesis in rats , 2002, Brain Research.

[88]  B. Kramer,et al.  p75 nerve growth factor receptor is important for retrograde transport of neurotrophins in adult cholinergic basal forebrain neurons , 1999, Neuroscience.

[89]  Anthony R. McIntosh,et al.  The Effects of Divided Attention on Encoding- and Retrieval-Related Brain Activity: A PET Study of Younger and Older Adults , 2000, Journal of Cognitive Neuroscience.

[90]  R. Nebes,et al.  Focused and Divided Attention in Alzheimer's Disease , 1989, Cortex.

[91]  Fergus I. M. Craik,et al.  Aging and Cognitive Deficits , 1982 .

[92]  N Butters,et al.  Directed and divided attention in Alzheimer's disease: impairment in shifting of attention to global and local stimuli. , 1992, Journal of clinical and experimental neuropsychology.

[93]  G. Small The role of neuroimaging in the diagnosis of vascular dementia , 2002, Acta neurologica Scandinavica. Supplementum.

[94]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[95]  N. Muzyczka,et al.  NGF gene transfer to intrinsic basal forebrain neurons increases cholinergic cell size and protects from age-related, spatial memory deficits in middle-aged rats , 2000, Brain Research.

[96]  T. Beach,et al.  The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease , 2000, Journal of neuropathology and experimental neurology.

[97]  P. Dijkhuizen,et al.  Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease , 1996, Neuroscience.

[98]  M. O'Neal,et al.  Role of nucleus basalis in cholinergic control of cortical blood flow , 1991, Journal of neuroscience research.

[99]  D. Salat,et al.  Intraseptal injection of the cholinergic immunotoxin 192-IgG saporin fails to disrupt latent inhibition in a conditioned taste aversion paradigm , 1996, Brain Research.

[100]  ML Voytko,et al.  Basal forebrain lesions in monkeys disrupt attention but not learning and memory [published erratum appears in J Neurosci 1995 Mar;15(3): following table of contents] , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[101]  M. Sarter,et al.  Age-related changes in rodent cortical acetylcholine and cognition: main effects of age versus age as an intervening variable , 1998, Brain Research Reviews.

[102]  M. Sarter,et al.  Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents , 1999, Neuroscience.

[103]  M. Gallagher,et al.  Selective immunotoxic lesions of basal forebrain cholinergic cells: effects on learning and memory in rats. , 1995, Behavioral neuroscience.

[104]  J. Brandt,et al.  Intelligence and education as predictors of cognitive state in late life , 1995, Neurology.

[105]  L O'Hanlon,et al.  Age Differences in Implicit and Explicit Associative Memory: Exploring Elaborative Processing Effects , 2001, Experimental aging research.

[106]  K. Kawashima,et al.  Nicotine-induced NO-mediated increase in cortical cerebral blood flow is blocked by β2-adrenoceptor antagonists in the anesthetized rats , 2002, Autonomic Neuroscience.

[107]  J. Cerella,et al.  Aging and dual-task performance: a meta-analysis. , 2003, Psychology and aging.

[108]  T. Robbins,et al.  Distinct Changes in Cortical Acetylcholine and Noradrenaline Efflux during Contingent and Noncontingent Performance of a Visual Attentional Task , 2001, The Journal of Neuroscience.

[109]  L. Maffei,et al.  Expression of the Nerve Growth Factor Receptors Trka and P75 Ntr in the Visual Cortex of the Rat: Development and Regulation by the Cholinergic Input , 2022 .

[110]  S. Leurgans,et al.  Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. , 2003, Archives of neurology.

[111]  E. Mackenzie,et al.  Cortical blood flow increases induced by stimulation of the substancia innominata in the unanesthetized rat , 1989, Brain Research.

[112]  Vladimir V. Frolkis,et al.  Neurobiology of Aging , 2019, Psychobiology of Behaviour.

[113]  C. Duyckaerts,et al.  The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy , 2003, Neurobiology of Aging.

[114]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[115]  M. King,et al.  Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain , 1999, Neuroscience.

[116]  M. Sofroniew,et al.  Reduced transport of [125I]nerve growth factor by cholinergic neurons and down-regulated trka expression in the medial septum of aged rats , 1994, Neuroscience.

[117]  T. Crook,et al.  Age-associated memory impairment: diagnostic criteria and treatment strategies. , 1987, International journal of neurology.

[118]  R. Quirion,et al.  Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies , 2002, Progress in Neurobiology.

[119]  O. Isacson,et al.  Cortico‐hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice , 2002, The European journal of neuroscience.

[120]  W H Brouwer,et al.  Divided Attention in Experienced Young and Older Drivers: Lane Tracking and Visual Analysis in a Dynamic Driving Simulator , 1991, Human factors.

[121]  A. Fagan,et al.  A Role for TrkA during Maturation of Striatal and Basal Forebrain Cholinergic Neurons In Vivo , 1997, The Journal of Neuroscience.

[122]  S. Arneric,et al.  Nicotinic agonists modulate basal forebrain control of cortical cerebral blood flow in anesthetized rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[123]  L. Thal,et al.  The decline in synapses and cholinergic activity is asynchronous in Alzheimer’s disease , 2000, Neurology.

[124]  David A Lewis,et al.  Schizophrenia as a disorder of neurodevelopment. , 2002, Annual review of neuroscience.

[125]  D R Wekstein,et al.  Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. , 1996, JAMA.

[126]  N. Berardi,et al.  Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice , 2000 .

[127]  J. Hodges,et al.  The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer’s disease: relationship to episodic and semantic memory impairment , 2000, Neuropsychologia.

[128]  F. Kagitani,et al.  Effects of stimulating the nucleus basalis of Meynert on blood flow and delayed neuronal death following transient ischemia in the rat cerebral cortex. , 2002, The Japanese journal of physiology.

[129]  J. Sullivan,et al.  (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization. , 1994, The Journal of pharmacology and experimental therapeutics.

[130]  J. Thornby,et al.  Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging , 2002, Journal of the Neurological Sciences.

[131]  R. Kalaria Similarities between Alzheimer's disease and vascular dementia , 2002, Journal of the Neurological Sciences.

[132]  J. Morris,et al.  Evidence That Age-Associated Memory Impairment Is Not a Normal Variant of Aging , 2001, Alzheimer disease and associated disorders.

[133]  F. Pirozzolo,et al.  Brain choline acetyltransferase and mental function in Alzheimer disease. , 1999, Archives of neurology.

[134]  J. Haxby,et al.  Cholinergic enhancement and increased selectivity of perceptual processing during working memory. , 2000, Science.

[135]  Raja Parasuraman,et al.  Divided attention and metabolic brain dysfunction in mild dementia of the Alzheimer's type , 1991, Neuropsychologia.

[136]  S. Scott,et al.  Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. , 1996, Brain research. Molecular brain research.

[137]  Karen Thompson,et al.  Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model , 1992, Brain Research Reviews.

[138]  L. Nilsson Memory function in normal aging , 2003, Acta neurologica Scandinavica. Supplementum.

[139]  D. Price,et al.  Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates , 1991, Annals of neurology.

[140]  M. Baxter,et al.  Cholinergic and noncholinergic septal neurons modulate strategy selection in spatial learning , 2001, The European journal of neuroscience.

[141]  E. Perry,et al.  Acetylcholine in mind: a neurotransmitter correlate of consciousness? , 1999, Trends in Neurosciences.

[142]  R. Schliebs,et al.  Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human β-amyloid precursor protein , 2002, Brain Research.

[143]  O. Inanami,et al.  Stimulation of the nucleus basalis of Meynert increases cerebral cortical blood flow in rats , 1989, Neuroscience Letters.

[144]  T. Mitzner,et al.  Language decline across the life span: findings from the Nun Study. , 2001, Psychology and aging.

[145]  S. Arneric,et al.  Cortical cerebral blood flow governed by the basal forebrain: Age-related Impairments , 1991, Neurobiology of Aging.

[146]  M. Nader,et al.  Imaging of cholinergic terminals using the radiotracer [18F](+)‐4‐fluorobenzyltrozamicol: In vitro binding studies and positron emission tomography studies in nonhuman primates , 1997, Synapse.

[147]  S. L. Mobley,et al.  Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[148]  R Parasuraman,et al.  Genetics and visual attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[149]  B. Reisberg,et al.  Mild cognitive impairment in the elderly , 1991, Neurology.

[150]  D. Holtzman,et al.  Nerve growth factor and the neurotrophic factor hypothesis , 1996, Brain and Development.

[151]  G. J. Crystal,et al.  Regional blood flow in canine brain during nicotine infusion: effect of autonomic blocking drugs. , 1983, Stroke.

[152]  R Parasuraman,et al.  Skill development in vigilance: effects of event rate and age. , 1991, Psychology and aging.

[153]  P. Luiten,et al.  Cortical projection patterns of magnocellular basal nucleus subdivisions as revealed by anterogradely transportedPhaseolus vulgaris leucoagglutinin , 1987, Brain Research.

[154]  E. Mufson,et al.  Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate , 1996, Brain Research.

[155]  R. Quirion,et al.  Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[156]  X. Tong,et al.  Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease , 1999, Neuroscience.

[157]  M. Sarter,et al.  Interactions between aging and cortical cholinergic deafferentation on attention☆ , 2002, Neurobiology of Aging.

[158]  K. Davis,et al.  Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[159]  E. Cochran,et al.  Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease , 2000, The Journal of comparative neurology.

[160]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[161]  Differential effects of selective immunotoxic lesions of medial septal cholinergic cells on spatial working and reference memory. , 1996, Behavioral neuroscience.

[162]  K Ball,et al.  Visual attention impairments in Alzheimer’s disease , 2000, Neurology.

[163]  M. Sarter,et al.  Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention , 2002, Neuroscience.

[164]  G. Baylis,et al.  The Role of Attention in a Spatial Memory Task in Alzheimer Disease Patients , 1997, Alzheimer Disease and Associated Disorders.

[165]  E. Tangalos,et al.  Memory function in normal aging , 1992, Neurology.

[166]  Changiz Geula,et al.  Abnormalities of neural circuitry in Alzheimer's disease , 1998, Neurology.

[167]  A. Baddeley,et al.  Attentional control in Alzheimer's disease. , 2001, Brain : a journal of neurology.

[168]  J. C. Torre,et al.  Evidence that Alzheimer’s disease is a microvascular disorder: the role of constitutive nitric oxide , 2000, Brain Research Reviews.

[169]  G. Wörtwein,et al.  Cholinergic Control of Nerve Growth Factor in Adult Rats: Evidence from Cortical Cholinergic Deafferentation and Chronic Drug Treatment , 1997, Journal of neurochemistry.

[170]  M. Sarter,et al.  Cognitive functions of cortical acetylcholine: toward a unifying hypothesis , 1997, Brain Research Reviews.

[171]  Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders , 1999 .

[172]  O. Inanami,et al.  Responses of regional cerebral blood flow following focal electrical stimulation of the nucleus basalis of Meynert and the medial septum using the [14C]iodoantipyrine method in rats , 1990, Neuroscience Letters.

[173]  J. Lauterborn,et al.  Neonatal treatment with 192 IgG-saporin produces long-term forebrain cholinergic deficits and reduces dendritic branching and spine density of neocortical pyramidal neurons. , 1998, Cerebral cortex.

[174]  R. Bucks,et al.  Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful , 2003, Journal of neurology, neurosurgery, and psychiatry.

[175]  P. Grammas,et al.  Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain. , 2002, The American journal of pathology.

[176]  R. Quirion,et al.  Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain , 1996, The Journal of comparative neurology.

[177]  J. Haxby,et al.  Attention and brain function in Alzheimer's disease: A review. , 1993 .

[178]  W. Meck,et al.  Organizational changes in cholinergic activity and enhanced visuospatial memory as a function of choline administered prenatally or postnatally or both. , 1989, Behavioral neuroscience.

[179]  T. Beach,et al.  Reduction of cortical amyloid β levels in guinea pig brain after systemic administration of physostigmine , 2001, Neuroscience Letters.

[180]  T. Beach,et al.  Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition , 2000, Neuroscience Letters.

[181]  M. Sarter,et al.  Attentional functions of cortical cholinergic inputs: What does it mean for learning and memory? , 2003, Neurobiology of Learning and Memory.

[182]  C. Geula,et al.  Loss of calbindin‐D28k from aging human cholinergic basal forebrain: Relation to neuronal loss , 2003, The Journal of comparative neurology.

[183]  Patrik Vuilleumier,et al.  Effects of attention and emotion on repetition priming and their modulation by cholinergic enhancement. , 2003, Journal of neurophysiology.

[184]  M. Decker,et al.  Effects of intraseptal injection of 192-IgG-saporin in mature and aged Long-Evans rats , 1996, Brain Research.

[185]  John R Hodges,et al.  Dissociation between top‐down attentional control and the time course of visual attention as measured by attentional dwell time in patients with mild cognitive impairment , 2003, The European journal of neuroscience.

[186]  J. Price,et al.  Absence of cognitive impairment or decline in preclinical Alzheimer’s disease , 2001, Neurology.

[187]  P. Luiten,et al.  Ultrastructural localization of cholinergic muscarinic receptors in rat brain cortical capillaries , 1996, Brain Research.

[188]  M. Sarter,et al.  Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. , 1996, Behavioral neuroscience.

[189]  M. Sofroniew,et al.  Increased vulnerability of septal cholinergic neurons to partial loss of target neurons in aged rats , 1996, Neuroscience.

[190]  G. Sedvall,et al.  Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer’s disease , 2000, Psychopharmacology.

[191]  R. Neve,et al.  Alzheimer’s disease: a dysfunction of the amyloid precursor protein 1 1 Published on the World Wide Web on 11 September 2000. , 2000, Brain Research.

[192]  R. Bartus,et al.  On Neurodegenerative Diseases, Models, and Treatment Strategies: Lessons Learned and Lessons Forgotten a Generation Following the Cholinergic Hypothesis , 2000, Experimental Neurology.

[193]  L. Harrell,et al.  Cholinergic activity and amyloid precursor protein metabolism , 1997, Brain Research Reviews.

[194]  A. Granholm,et al.  Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh , 2002, Trends in Neurosciences.

[195]  E. Mufson,et al.  Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases , 1999, Progress in Neurobiology.

[196]  T. Robbins,et al.  Sparing of attentional relative to mnemonic function in a subgroup of patients with dementia of the Alzheimer type , 1990, Neuropsychologia.

[197]  J. Price,et al.  Cerebral amyloid deposition and diffuse plaques in ``normal'' aging , 1996, Neurology.

[198]  W. A. Wilson,et al.  Prenatal Choline Supplementation Protects against Postnatal Neurotoxicity , 2002, The Journal of Neuroscience.

[199]  M. Sarter,et al.  Microsphere embolism‐induced cortical cholinergic deafferentation and impairments in attentional performance , 2005, The European journal of neuroscience.

[200]  M. Sarter,et al.  Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats. , 1997, Brain research. Cognitive brain research.

[201]  L. Wilkinson,et al.  Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system , 1994, Neuroscience.

[202]  S. Takeo,et al.  Failure in learning task and loss of cortical cholinergic fibers in microsphere-embolized rats , 1997, Experimental Brain Research.

[203]  F. Craik,et al.  The attentional demands of encoding and retrieval in younger and older adults: 1. Evidence from divided attention costs. , 1998, Psychology and aging.

[204]  U. Ueberham,et al.  In Vivo Regulation of Amyloid Precursor Protein Secretion in Rat Neocortex by Cholinergic Activity , 1997, European Journal of Neuroscience.

[205]  Lars Bäckman,et al.  Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project. , 2002, The American journal of psychiatry.

[206]  D. Donnelly-roberts,et al.  (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. , 1994, The Journal of pharmacology and experimental therapeutics.

[207]  B. Sahakian,et al.  Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB , 2005, Psychopharmacology.

[208]  James A. Mortimer,et al.  Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .

[209]  Raja Parasuraman,et al.  Genetics and visual attention: Selective deficits in healthy adult carriers of the ɛ4 allele of the apolipoprotein E gene , 2000 .

[210]  O. Scremin,et al.  Selective immunotoxin-induced cholinergic deafferentation alters blood flow distribution in the cerebral cortex , 1999, Brain Research.

[211]  R. Quirion,et al.  Amyloid β‐Peptide Inhibits High‐Affinity Choline Uptake and Acetylcholine Release in Rat Hippocampal Slices , 1998 .

[212]  Y. Li,et al.  Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[213]  E. Hamel,et al.  Cholinergic basal forebrain projections to nitric oxide synthase-containing neurons in the rat cerebral cortex , 1997, Neuroscience.

[214]  M. Sarter,et al.  The cognitive neuroscience of sustained attention: where top-down meets bottom-up , 2001, Brain Research Reviews.

[215]  Jennifer A. Mangels,et al.  Memory and Cognitive Abilities in University Professors: Evidence for Successful Aging , 1995 .

[216]  R. Parasuraman,et al.  Sensory and Cognitive Vigilance: Effects of Age on Performance and Subjective Workload , 1993 .

[217]  J V Haxby,et al.  Visuospatial attention in dementia of the Alzheimer type. , 1992, Brain : a journal of neurology.

[218]  E. Pioro,et al.  Neocortical infarction in subhuman primates leads to restricted morphological damage of the cholinergic neurons in the nucleus basalis of Meynert , 1994, Brain Research.

[219]  D Wyper,et al.  Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[220]  P. Grammas,et al.  Inflammatory factors are elevated in brain microvessels in Alzheimer’s disease , 2001, Neurobiology of Aging.

[221]  D. K. Berg,et al.  β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.